Industry snapshot
Key public data points
Historical & forecast
Base year 2023. Each series is official through its own latest government-data year (shown in the legend on each chart), and years beyond that are Claight estimates. As of July 2026 the current year is still in progress (2026 annual data is not yet published), so the forecast runs to 2028.
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Industry Definition and Scope
What does the Eye Surgery Clinics in European Union industry cover?
The industry encompasses independent ambulatory surgical centers, specialized ophthalmic hospitals, and dedicated clinics providing surgical interventions for the human eye. Core services include corrective refractive surgery, corneal procedures, glaucoma treatments, and vitreoretinal operations.
- •Primary classification falls under NACE Rev. 2 code 86.22 (Specialised medical practice activities) or 86.10 (Hospital activities) depending on local licensing structure.
- •Scope isolates surgical eye procedures from routine optometric testing, lens manufacturing, and non-surgical ophthalmic pharmaceuticals.
- •The absolute majority of operations are minimally invasive, high-volume day procedures performed without general anesthesia.
Market Structure and Operators
Who operates in the industry and how is it structured?
The operational structure across the EU is highly bifurcated between state-reimbursed public healthcare facilities and corporate-backed private medical groups. System structures vary widely by member state, directly influencing how patients are admitted and treated.
- •In 2023, the operational format favored day-care admissions, with day patients accounting for 55.8% of EU cataract procedures and out-patients making up 37.8%.
- •Certain Eastern European nations retain legacy institutional structures, where in-patients required to stay overnight represented 57.0% of cases in Romania and 54.7% in Bulgaria during 2023.
- •Conversely, out-patient care models dominated Western markets in 2023, capturing 91.9% of procedures in Italy and 87.9% in Germany.
Demand Drivers
What drives demand in the industry?
The volume of surgical eye procedures is structurally propelled by demographic aging across European populations and the universal prevalence of age-related vision degradation. Advancements in micro-surgical instruments have simultaneously expanded patient eligibility criteria.
- •Eurostat reported a stark regional volume imbalance in 2023, led by Luxembourg with 1,627.3 surgeries per 100,000 people and France at 1,598.7 surgeries per 100,000 people.
- •Rising instances of age-related macular degeneration (AMD) and diabetic retinopathy are driving demand for secondary surgical therapies.
- •Increased consumer willingness to pay out-of-pocket for premium multi-focal lenses and laser vision correction accelerates private clinic revenue.
Competitive Landscape and Notable Public Companies
Who are the notable companies in the industry?
The European private eye clinic landscape is consolidating rapidly, shifting away from fragmented doctor-owned practices toward multi-national healthcare networks funded by major consumer health conglomerates and corporate holding firms. These scale players expand through strategic consolidation across Western and Central Europe.
- •EssilorLuxottica Group operates a dominant pan-European network containing over 70 hospitals and diagnostic facilities under its Optegra brand.
- •Sanoptis serves as a primary regional competitor with more than 465 locations across Germany, Switzerland, Italy, Spain, Austria, and Greece.
- •The Czech Republic and Slovakia are heavily served by Lexum, an established regional specialist network operating within the wider corporate ecosystem.
- •Iris Eye Clinic acts as a localized branded clinic partner capturing outpatient surgical demand within the Netherlands.
Recent Trends and Outlook
What are the recent trends and outlook?
Operational strategies are prioritizing the rapid rollout of specialized, standalone ambulatory centers to lower the overhead costs associated with full-scale general hospitals. Technological innovation centers around digital integration and the deployment of femtosecond laser technology.
- •The industry is experiencing a post-pandemic clearing of public waitlists, pushing higher volumes into private clinic sub-contractors.
- •Corporate networks are scaling standardized patient pathways across borders to combat localized doctor shortages and rising staffing costs.
- •Premium intraocular lens (IOL) upsells are increasingly utilized to sustain profit margins amid inflating regulatory overheads.
Regulation and Compliance
How is the industry regulated?
Operators must strictly conform to individual member state health system licensing while navigating overarching European Union medical apparatus rules. Compliance demands for tracking clinical outcomes and sterilizing multi-use surgical instruments have intensified.
- •Facilities must utilize medical devices certified under the stringent EU Medical Device Regulation (MDR 2017/745), which dictates tight traceabilities for implants.
- •Public reimbursement levels set by national bodies like the French Haute Autorité de Santé (HAS) or German statutory health insurances dictate regional clinical profit structures.
- •Data collection protocols must adhere to GDPR frameworks given the high volume of digital diagnostic imaging and biometric eye data stored by clinic groups.
Sources
Government, statistical and trade sources used for this Claight analysis.
- Eurostat Surgical Operations and Procedures Statistics 2026 ·
- EssilorLuxottica Group Corporate Profile 2025/2026 ·
- Groupe Bruxelles Lambert (GBL) Sanoptis Portfolio Review 2026 ·
- European Parliament and Council Medical Device Regulation (EU) 2017/745
Claight analysis of public industry data.